Biogen Idec gains MS drug approval
258793
The US government approved a drug Tuesday to treat multiple sclerosis, an incurable disease of the central nervous system that affects 350,000 Americans.
149931
SAN FRANCISCO (CBS.MW) -- Shares of Elan Corp. and Biogen Idec rose in premarket trade Wednesday after the US Food and Drug Administration approved the companies&#39; multiple sclerosis drug Tysabri.
619333
A trio of generic drug companies announces FDA approval of their versions of the blockbuster drug Coreg.
293341
Biogen Idec Inc.&#39;s Tysabri drug for multiple sclerosis may reach patients as soon as next week, and doctors said they plan to prescribe it first to patients who are no longer being helped by older medicines.
16443
Biogen and Elan receive an additional approval for Tysabri.
563410
25/11/2004 - The first in a completely new class of drug for multiple sclerosis has been approved in the US, opening up a new avenue of treatment for sufferers of the debilitating diseases and potential blockbuster revenues for developers Elan and Biogen
18314
WASHINGTON -- The government has approved a drug that tries a new method of attacking multiple sclerosis, an incurable disease of the central nervous system that affects 350,000 Americans.
624941
Two lupus patients died from a rare  brain infection after taking the Genentech and Biogen Idec drug  Rituxan, U.S. health officials said in an advisory issued on  Monday.
510674
NEW YORK, November 19  - Tarceva, an experimental lung cancer drug, has been approved by the Food &amp; Drug Administration, Genentech (DNA.
60593
Drug maker Bristol-Myers Squibb Co. and Otsuka Pharmaceutical Co. said Friday that the Food and Drug Administration approved their antipsychotic drug Abilify for the treatment of acute bipolar mania.
59608
Standard &amp; Poor&#39;s Equity Research reiterated a &quot;hold&quot; rating and $68 target price on Biogen Idec (nasdaq: BIIB - news - people ), saying the anticipated success of the company&#39;s Antegren drug is largely factored into the share price.
214879
DUBLIN -- US drug company Biogen Idec is considering an all-share bid of more than 8.5 billion euros ($10.6 billion) for Irish peer Elan , a newspaper reported yesterday.
81579
BOSTON  â Biogen Idec said on Wednesday its fourth-quarter profit rose 84 percent, topping expectations, driven by increased sales of its multiple sclerosis drugs Avonex and Tysabri.
394537
A breakthrough cancer drug made by a Long Island company won federal approval late Thursday in a major victory for cancer patients and the region&#39;s budding biotech industry.
337666
SAN FRANCISCO -- Billionaire investor Carl C. Icahn was given clearance by US antitrust regulators to purchase shares in Biogen Idec Inc., the world's biggest maker of drugs for multiple sclerosis.
468910
Biomira reports favorable Phase II test results.
440572
The government approved a drug Tuesday that tries a new method of attacking multiple sclerosis, an incurable disease of the central nervous system that affects 350,000 Americans.